Retinal Protective Effects of Resveratrol via Modulation of Nitric Oxide Synthase on Oxygen-induced Retinopathy

키워드

참고문헌 (53)

1. Palmer EA, "Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group", Ophthalmology, 98, pp.1628~1640 (1991)
2. Mantagos IS, "Emerging treatments for retinopathy of prematurity", Semin Ophthalmol, 24, pp.82~86 (2009)
3. Palmer EA, "15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity", Arch Ophthalmol, 123, pp.311~318 (2005)
4. Good WV, "Retinopathy of prematurity and the peripheral retina", J Pediatr, 153, pp.591~592 (2008)
5. Heidary G, "Retinopathy of prematurity: current concepts in molecular pathogenesis", Semin Ophthalmol, 24, pp.77~81 (2009)
6. Penn JS, "Variable oxygen exposure causes preretinal neovascularization in the newborn rat", Invest Ophthalmol Vis Sci, 34, pp.576~585 (1993)
7. Seigel GM, "Establishment of an E1A-immortalized retinal cell culture", In vitro Cell Dev Biol Anim, 32, pp.66~68 (1996)
8. Soleas GJ, "Wine as a biological fluid: history, production, and role in disease prevention", J Clin Lab Anal, 11, pp.287~313 (1997)
9. Creasy LL, "Phytoalexin production potential of grape berries", J Am Soc Hortic Sci, 113, pp.230~234 (1988)
10. Sun AY, "The "French Paradox" and beyond: neuroprotective effects of polyphenols", Free Radic Biol Med, 32, pp.314~318 (2002)
11. Frankel EN, "Inhibition of human LDL oxidation by resveratrol", Lancet, 341, pp.1103~1104 (1993)
12. Shin NH, "Inhibitory effects of hydroxystilbenes on cyclooxygenase from sheep seminal vesicles", Planta Med, 64, pp.283~284 (1998)
13. Bertelli AA, "Antiplatelet activity of synthetic and natural resveratrol in red wine", Int J Tissue React, 17, pp.1~3 (1995)
14. Chen CK, "Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta", Gen Pharmacol, 27, pp.363~366 (1996)
15. 서민애, "The expression patterns of nitric oxide synthases (NOS) by resveratrol in hypoxic-ischemic brain injury in neonatal rat model", 대한주산의학회잡지, 19(3), pp.283~292 (2008), 대한주산의학회
16. Lee HJ, "The expression of nitric oxide synthase (NOS) isoforms in relation to Resveratrol administration in hypoxic injury of myocardial cells", J Korean Pediatr Cardiol Soc, 11, pp.199~205 (2007)
17. Mosmann T, "Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays", J Immunol Methods, 65, pp.55~63 (1983)
18. Terry TL, "Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens", Am J Ophthalmol, 25, pp.203~204 (1942)
19. Terry TL, "Fibroblastic overgrowth of persistent tunica vasculosa lentis in premature infants, II: report of cases-clinical aspects", Arch Ophthalmol, 29, pp.36~53 (1943)
20. Owens WC, "Retrolental fibroplasia in premature infants", Am J Ophthalmol, 32, pp.1~29 (1949)
21. Kinsey VE, "Retrolental fibroplasia. cooperative study of re- trolental fibroplasia and the use of oxygen", AMA Arch Ophthalmol, 56, pp.481~543 (1956)
22. Rubaltelli DM, "Retinopathy of prematurity update", Int Ophthalmol Clin, 48, pp.225~235 (2008)
23. Fleck BW, "Pathogenesis of retinopathy of prematurity and possible preventive strategies", Early Hum Dev, 84, pp.83~88 (2008)
24. Hughes S, "Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis", Invest Ophthalmol Vis Sci, 41, pp.1217~1228 (2000)
25. Leske DA, "The role of VEGF and IGF-1 in a hypercarbic oxygen-induced retinopathy rat model of ROP", Mol Vis, 10, pp.43~50 (2004)
26. Chen J, "Retinopathy of prematurity", Angiogenesis, 10, pp.133~140 (2007)
27. Cunningham S, "Trans- cutaneous oxygen levels in retinopathy of prematurity", Lancet, 346, pp.1464~1465 (1995)
28. McColm JR, "Hypoxic oxygen fluctuations produce less severe retinopathy than hyperoxic fluctuations in a rat model of retinopathy of prematurity", Pediatr Res, 55, pp.107~113 (2004)
29. Seigel GM, "The golden age of retinal cell culture", Mol Vis, 5, pp.4~ (1999)
30. Politi LE, "Generation of enriched populations of cultured photoreceptor cells", Invest Ophthalmol Vis Sci, 27, pp.656~665 (1986)
31. Cahill GM, "Light-sensitive melatonin synthesis by Xenopus photoreceptors after destruction of the inner retina", Vis Neurosci, 8, pp.487~490 (1992)
32. Wang X, "A new technique for isolation of photoreceptor layer", Zhonghua Yan Ke Za Zhi, 32, pp.304~306 (1996)
33. Seigel GM, "Expression of glial markers in a retinal precursor cell line", Mol Vis, 2, pp.2~ (1996)
34. Laabich A, "Protective effect of crocin against blue light- and white light-mediated photoreceptor cell death in bovine and primate retinal primary cell culture", Invest Ophthalmol Vis Sci, 47, pp.3156~3163 (2006)
35. Moncada S, "The L-arginine-nitric oxide pathway", N Engl J Med, 329, pp.2002~2012 (1993)
36. Riddell DR, "Nitric oxide and platelet aggregation", Vitam Horm, 57, pp.25~48 (1999)
37. Konishi R, "Nitric oxide prevents human platelet adhesion to fiber membranes in whole blood", ASAIO J, 42, pp.M850~M853 (1996)
38. Dal Secco D, "Neutrophil migration in inflammation: nitric oxide inhibits rolling, adhesion and induces apoptosis", Nitric Oxide, 9, pp.153~164 (2003)
39. Faraci FM, "Nitric oxide and the cerebral circulation", Stroke, 25, pp.692~703 (1994)
40. Morikawa E, "L-arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat", Stroke, 25, pp.429~435 (1994)
41. Alderton WK, "Nitric oxide synthases: structure, function and inhibition", Biochem J, 357, pp.593~615 (2001)
42. Tsai SK, "Resveratrol neuroprotec- tive effects during focal cerebral ischemia injury via nitric oxide mechanism in rats", J Vasc Surg, 46, pp.346~353 (2007)
43. Rotondo S, "Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function", Br J Pharmacol, 123, pp.1691~1699 (1998)
44. Aggarwal BB, "Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies", Anticancer Res, 24, pp.2783~2840 (2004)
45. Love S, "Oxidative stress in brain ischemia", Brain Pathol, 9, pp.119~131 (1999)
46. Huang SS, "Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia", Life Sci, 69, pp.1057~1065 (2001)
47. Hattori R, "Pharmacological preconditioning with resveratrol: role of nitric oxide", Am J Physiol Heart Circ Physiol, 282, pp.H1988~H1995 (2002)
48. Chung EY, "Anti-inflammatory effect of the oligomeric stilbene alpha-Viniferin and its mode of the action through inhibition of cyclooxygenase-2 and inducible nitric oxide synthase", Planta Med, 69, pp.710~714 (2003)
49. Wallerath T, "Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase", Circulation, 106, pp.1652~1658 (2002)
50. Chan MM, "Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway", Biochem Pharmacol, 60, pp.1539~1548 (2000)
51. Uchida Y, "Enhancement of NF-kappaB activity by resveratrol in cytokine-exposed mesangial cells", Clin Exp Immunol, 142, pp.76~83 (2005)
52. King RE, "Resveratrol reduces oxidation and proliferation of human retinal pigment epithelial cells via extracellular signal-regulated kinase inhibition", Chem Biol Interact, 151, pp.143~149 (2005)
53. Notas G, "Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation", Biochim Biophys Acta, 1760, pp.1657~1666 (2006)

관련 논문AI추천